Xolair 150 MG/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTPT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,590
Award facts
- Contract value 100% obligated
- $23,590.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,590.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml. The award, issued on February 4, 2026, with an ultimate completion date of February 23, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare operations worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its established small business status to compete in unrestricted federal procurement. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with demonstrated consistent performance across multiple therapeutic categories. The PPV-G GEN V contract, awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors responsible for fulfilling the diverse and specialized pharmaceutical requirements of the military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTPT?
SPE2DR26FBTPT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FBTPT worth?
The government has obligated $23,590 on SPE2DR26FBTPT.
Is contract SPE2DR26FBTPT an order under another contract?
Yes. SPE2DR26FBTPT is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTPT competed?
The extent of competition for SPE2DR26FBTPT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award